Skip to main content

Table 2 Univariate COX proportional hazard analysis

From: Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?

 

RFS

MFS

OS

 

HR

95%CI

p-value

HR

95%CI

p-value

HR

95%CI

p-value

Male

4.9 × 108

/

0.998

0.78

0.33–1.84

0.573

0.67

0.24–1.86

0.447

Age ≥ 60

0.59

0.13–2.65

0.495

1.45

0.58–3.61

0.423

3.32

0.09–11.7

0.063

Size ≥ 10 cm

0.84

0.18–3.78

0.828

0.98

0.41–2.31

0.965

1.66

0.59–4.67

0.335

Superficial

0.25

0.03–2.11

0.204

0.88

0.35–2.18

0.787

1.11

0.39–3.15

0.830

Trunk

2.49

0.55–11.2

0.233

1.71

0.72–4.05

0.218

2.09

0.75–5.81

0.154

DD

1.11

0.77–1.59

0.562

1.26

1.07–1.50

0.0061

1.33

1.11–1.58

0.0014

PIC

1.26

0.60–2.65

0.534

2.39

1.59–3.58

0.00003

1.99

1.42–2.79

0.00006

SF

1.02

0.98–1.07

0.219

1.02

0.99–1.04

0.096

1.02

1.01–1.05

0.026

TAT

0.95

0.71–1.27

0.736

0.98

0.89–1.09

0.829

1.01

0.92–1.10

0.855

High grade

0.025

0.0-16.2

0.264

39.3

0.79–1957

0.065

67.2

0.76–51.3

0.087

Stage I, II vs. III, IV

6.20

1.19-32.1-

0.029

3.34

1.40–7.96

0.007

5.66

1.98–16.1

0.0011

  1. Plasma DD, PIC, SF and TAT levels were analyzed as continuous variables